These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 26053162)

  • 21. SUMO on the road to neurodegeneration.
    Dorval V; Fraser PE
    Biochim Biophys Acta; 2007 Jun; 1773(6):694-706. PubMed ID: 17475350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention.
    Briston T; Hicks AR
    Biochem Soc Trans; 2018 Aug; 46(4):829-842. PubMed ID: 29986938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality control of the proteins associated with neurodegenerative diseases.
    Gao X; Hu H
    Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):612-8. PubMed ID: 18604452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Removing protein aggregates: the role of proteolysis in neurodegeneration.
    Nijholt DA; De Kimpe L; Elfrink HL; Hoozemans JJ; Scheper W
    Curr Med Chem; 2011; 18(16):2459-76. PubMed ID: 21568912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
    Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
    Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
    Dohm CP; Kermer P; Bähr M
    Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Filamentous Aggregates Are Fragmented by the Proteasome Holoenzyme.
    Cliffe R; Sang JC; Kundel F; Finley D; Klenerman D; Ye Y
    Cell Rep; 2019 Feb; 26(8):2140-2149.e3. PubMed ID: 30784595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau Oligomers.
    Maeda S; Takashima A
    Adv Exp Med Biol; 2019; 1184():373-380. PubMed ID: 32096050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteasome: a Nanomachinery of Creative Destruction.
    Kudriaeva AA; Belogurov AA
    Biochemistry (Mosc); 2019 Jan; 84(Suppl 1):S159-S192. PubMed ID: 31213201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Degradation of tau protein by autophagy and proteasomal pathways.
    Wang Y; Mandelkow E
    Biochem Soc Trans; 2012 Aug; 40(4):644-52. PubMed ID: 22817709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ubiquitin-proteasome system in neurodegeneration.
    McKinnon C; Tabrizi SJ
    Antioxid Redox Signal; 2014 Dec; 21(17):2302-21. PubMed ID: 24437518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precise assembly and regulation of 26S proteasome and correlation between proteasome dysfunction and neurodegenerative diseases.
    Im E; Chung KC
    BMB Rep; 2016 Sep; 49(9):459-73. PubMed ID: 27312603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in Proteasome Enhancement by Small Molecules.
    George DE; Tepe JJ
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidation and ubiquitination in neurodegeneration.
    Riederer BM; Leuba G; Elhajj Z
    Exp Biol Med (Maywood); 2013 May; 238(5):519-24. PubMed ID: 23856903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Terminal Ubiquitination of Amyloidogenic Proteins Triggers Removal of Their Oligomers by the Proteasome Holoenzyme.
    Ye Y; Klenerman D; Finley D
    J Mol Biol; 2020 Jan; 432(2):585-596. PubMed ID: 31518613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease and the autophagic-lysosomal system.
    Chung KM; Hernández N; Sproul AA; Yu WH
    Neurosci Lett; 2019 Apr; 697():49-58. PubMed ID: 29758300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SUMO and its role in human diseases.
    Sarge KD; Park-Sarge OK
    Int Rev Cell Mol Biol; 2011; 288():167-83. PubMed ID: 21482412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases.
    Desai S; Juncker M; Kim C
    Exp Biol Med (Maywood); 2018 Mar; 243(6):554-562. PubMed ID: 29316798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.
    Ciechanover A; Brundin P
    Neuron; 2003 Oct; 40(2):427-46. PubMed ID: 14556719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.